No recent analyst price targets found for VCNX.
Latest News for VCNX
Vaccinex Reports 2025 Annual Financial Results
ROCHESTER, N.Y., April 29, 2026 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (OTCMKTS:VCNX), a clinical-stage biotechnology company pioneering novel investigational antibody therapies in Alzheimer's, Huntington's disease, and cancer today released financial results for the year ended December 31, 2025. The financial statements have been posted on the company website.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for VCNX.
U.S. House Trading
No House trades found for VCNX.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.